Semler Scientific, Inc.(SMLR)Earnings, Financials & Key Ratios

SMLR•NASDAQ

$20.33

$311M mkt cap·4.0× P/E·Price updated Apr 24, 2026

SectorHealthcare IndustryMedical Devices Sub-IndustryPatient monitoring and wearable diagnostics

AboutSemler Scientific, Inc. provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers in the United States. The company's products include QuantaFlo, a four-minute in-office blood flow test that enables healthcare providers to use blood flow measurements as part of their examinations of a patient's vascular condition. Its products serve cardiologists, internists, nephrologists, endocrinologists, podiatrists, and family practitioners, as well as healthcare insurance plans, integrated delivery networks, independent physician groups, and companies contracting with the healthcare industry, such as risk assessment groups. The company offers its products through salespersons and distributors. Semler Scientific, Inc. was incorporated in 2007 and is headquartered in Santa Clara, California.Show more

Revenue$56M-17.4%
EBITDA$22M-5.9%
Net Income$41M+98.7%
EPS (Diluted)5.13+95.1%
Gross Margin91.55%+2.0%
EBITDA Margin38.21%+14.0%
Operating Margin37.19%+13.9%
Net Margin72.65%+140.7%
ROE27.04%-16.3%
ROIC13.26%-81.1%
Debt/Equity0.00-86.4%

Technical→

SMLR Key Insights

Semler Scientific, Inc. (SMLR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

✓Company is almost debt free
✓Excellent 3Y average ROE of 29.2%
✓Strong 5Y profit CAGR of 22.1%
✓Strong 5Y sales CAGR of 11.4%
✓Healthy 5Y average net margin of 39.4%
✓Trading at only 0.7x book value

✗Weaknesses

✗Negative free cash flow
✗Weak momentum: RS Rating 13 (bottom 13%)
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

SMLR Price & Volume

Semler Scientific, Inc. (SMLR) stock price & volume — 10-year historical chart

Loading chart...

SMLR Growth Metrics

Semler Scientific, Inc. (SMLR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years31.52%

5 Years11.43%

3 Years2.01%

TTM-37.29%

Profit CAGR

10 Years-

5 Years22.08%

3 Years33.42%

TTM203.75%

EPS CAGR

10 Years-

5 Years22.23%

3 Years34.25%

TTM35.52%

Return on Capital

10 Years-5.61%

5 Years41.51%

3 Years27.47%

Last Year13.71%

SMLR Recent Earnings

Semler Scientific, Inc. (SMLR) EPS & revenue vs analyst estimates — last 4 quarters

Full history →

●Beat EPS 10/12 qtrs (91%)●Beat Revenue 8/12 qtrs (80%)

Q1 2026Latest

Feb 17, 2026

EPS

$3.41

Est $0.54

+731.5%

Revenue

—

Est $3M

Q4 2025

Nov 12, 2025

EPS

$1.07

Est $0.04

+2575.0%

Revenue

$7M

Est $8M

-9.6%

Q3 2025

Aug 4, 2025

EPS

$5.04

Est $0.10

+5140.0%

Revenue

$8M

Est $8M

+2.8%

Q2 2025

May 13, 2025

EPS

$0.76

Revenue

$9M

Quarter	Date	EPS (Act vs Est)	Revenue (Act vs Est)
Q1 2026Latest	Feb 17, 2026	$3.41vs $0.54+731.5%	—vs $3M
Q4 2025	Nov 12, 2025	$1.07vs $0.04+2575.0%	$7Mvs $8M-9.6%
Q3 2025	Aug 4, 2025	$5.04vs $0.10+5140.0%	$8Mvs $8M+2.8%
Q2 2025	May 13, 2025	$0.76	$9M

Based on last 12 quarters of dataView full earnings history →

Company	Market Cap	Stock Price	P/E Ratio (TTM)	Revenue Growth 1Y	Net Margin	Return on Equity (ROE)	Debt / Equity
BEATHeartBeam, Inc.Direct Competitor	34.34M	0.86	-1.38			-5.71%
AEYEAudioEye, Inc.Direct Competitor	95.09M	7.66	-30.64	14.52%	-7.63%	-47.8%	0.15
GXAIGaxos.ai Inc.Direct Competitor	2.19M	1.23	-0.64	14.73%	-5.44%	-27.29%
ATECAlphatec Holdings, Inc.Direct Competitor	1.06B	6.99	-7.28	24.95%	-21.07%	-141.88%	17.21
MDXGMiMedx Group, Inc.Product Competitor	543.76M	3.66	11.44	19.99%	7.88%	12.86%	0.09
OFIXOrthofix Medical Inc.Product Competitor	489.36M	12.19	-5.35	2.85%	-7.27%	-13.44%	0.51
PRCTPROCEPT BioRobotics CorporationProduct Competitor	1.41B	24.80	-14.42	37.22%	-31.82%	-27.7%	0.14
UNHUnitedHealth Group IncorporatedSupply Chain	333.37B	367.28	27.76	11.81%	2.68%	11.54%	0.77

Compare SMLR vs Peers

Semler Scientific, Inc. (SMLR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs BEAT

Most directly comparable listed peer for SMLR.

Scale Benchmark

vs UNH

Larger-name benchmark to compare SMLR against a more recognizable public peer.

Peer Set

Compare Top 5

vs BEAT, AEYE, GXAI, ATEC

SMLR Income Statement

Semler Scientific, Inc. (SMLR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Sales/Revenue	7.43M	12.45M	21.49M	32.77M	38.6M	53.03M	56.69M	68.18M	56.29M	36.96M
Revenue Growth %	6.18%	67.5%	72.59%	52.47%	17.81%	37.36%	6.9%	20.28%	-17.44%	-37.29%
Cost of Goods Sold	1.87M	2.55M	2.7M	3.66M	3.36M	6.12M	4.25M	6.98M	4.76M	3.41M
COGS % of Revenue	25.2%	20.5%	12.58%	11.17%	8.69%	11.55%	7.5%	10.24%	8.45%	-
Gross Profit	5.56M▲ 0%	9.9M▲ 78.0%	18.79M▲ 89.8%	29.11M▲ 54.9%	35.25M▲ 21.1%	46.91M▲ 33.1%	52.43M▲ 11.8%	61.2M▲ 16.7%	51.53M▼ 15.8%	33.54M▲ 0%
Gross Margin %	74.8%	79.5%	87.42%	88.83%	91.31%	88.45%	92.5%	89.76%	91.55%	90.76%
Gross Profit Growth %	33.87%	78.01%	89.8%	54.92%	21.1%	33.08%	11.79%	16.72%	-15.79%	-
Operating Expenses	7.72M	10.75M	13.45M	18.4M	19.29M	27.46M	35.23M	38.94M	30.6M	68.54M
OpEx % of Revenue	103.85%	86.35%	62.57%	56.15%	49.96%	51.78%	62.15%	57.12%	54.36%	-
Selling, General & Admin	6.85M	8.92M	11.36M	15.92M	16.35M	23.68M	30.42M	32.44M	25.81M	34.1M
SG&A % of Revenue	92.2%	71.64%	52.86%	48.58%	42.35%	44.66%	53.67%	47.57%	45.85%	-
Research & Development	866K	1.83M	2.08M	2.48M	2.94M	3.78M	4.81M	5.77M	4.79M	4.69M
R&D % of Revenue	11.65%	14.7%	9.7%	7.57%	7.61%	7.13%	8.48%	8.47%	8.51%	-
Other Operating Expenses	0	-14K	-4K	-9K	0	0	0	734K	0	1000K
Operating Income	-2.16M▲ 0%	-853K▲ 60.5%	5.34M▲ 726.3%	10.71M▲ 100.4%	15.96M▲ 49.1%	19.45M▲ 21.8%	17.2M▼ 11.5%	22.26M▲ 29.4%	20.93M▼ 5.9%	-35M▲ 0%
Operating Margin %	-29.04%	-6.85%	24.86%	32.68%	41.35%	36.67%	30.35%	32.64%	37.19%	-94.71%
Operating Income Growth %	74.36%	60.49%	726.26%	100.45%	49.06%	21.83%	-11.53%	29.37%	-5.94%	-
EBITDA	-1.71M	-294K	5.84M	11.34M	16.54M	20.07M	17.79M	22.86M	21.51M	-34.59M
EBITDA Margin %	-22.96%	-2.36%	27.2%	34.61%	42.84%	37.84%	31.39%	33.52%	38.21%	-93.59%
EBITDA Growth %	78.94%	82.78%	2088.1%	94.01%	45.84%	21.34%	-11.34%	28.46%	-5.88%	-268.2%
D&A (Non-Cash Add-back)	452K	559K	503K	632K	577K	622K	589K	599K	579K	416K
EBIT	-2.16M	-1.05M	5.34M	10.71M	16.49M	19.45M	17.2M	22.99M	20.93M	-47.06M
Net Interest Income	-391K	-464K	-298K	2K	19K	10K	494K	2.47M	1.88M	-3.48M
Interest Income	0	0	0	2K	19K	10K	494K	2.47M	1.88M	178K
Interest Expense	391K	464K	298K	0	0	0	0	0	0	3.66M
Other Income/Expense	-395K	-657K	-302K	-7K	525K	10K	489K	1.84M	26.95M	97.08M
Pretax Income	-2.55M▲ 0%	-1.51M▲ 40.9%	5.04M▲ 433.8%	10.7M▲ 112.3%	16.49M▲ 54.1%	19.45M▲ 18.0%	17.69M▼ 9.1%	24.1M▲ 36.2%	47.88M▲ 98.7%	62.07M▲ 0%
Pretax Margin %	-34.36%	-12.13%	23.45%	32.66%	42.71%	36.69%	31.21%	35.35%	85.06%	167.96%
Income Tax	0	0	26K	-4.38M	2.48M	2.23M	3.37M	3.52M	6.99M	13.73M
Effective Tax Rate %	0%	0%	0.52%	-40.96%	15.04%	11.48%	19.03%	14.59%	14.59%	22.13%
Net Income	-2.55M▲ 0%	-1.51M▲ 40.9%	5.01M▲ 432.1%	15.08M▲ 200.8%	14.01M▼ 7.1%	17.22M▲ 23.0%	14.32M▼ 16.8%	20.58M▲ 43.7%	40.9M▲ 98.7%	48.34M▲ 0%
Net Margin %	-34.36%	-12.13%	23.33%	46.03%	36.28%	32.48%	25.27%	30.19%	72.65%	130.8%
Net Income Growth %	69.96%	40.88%	432.05%	200.84%	-7.14%	22.95%	-16.82%	43.69%	98.7%	203.75%
Net Income (Continuing)	-2.55M	-1.51M	5.01M	15.08M	14.01M	17.22M	14.32M	20.58M	40.9M	48.34M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.50▲ 0%	-0.28▲ 44.0%	0.66▲ 335.7%	1.88▲ 184.8%	1.74▼ 7.4%	2.12▲ 21.8%	1.79▼ 15.6%	2.63▲ 46.9%	5.13▲ 95.1%	2.92▲ 0%
EPS Growth %	70.93%	44%	335.71%	184.85%	-7.45%	21.84%	-15.57%	46.93%	95.06%	35.52%
EPS (Basic)	-0.50	-0.28	0.66	2.34	2.13	2.56	2.13	3.06	5.66	-
Diluted Shares Outstanding	5.12M	5.41M	7.63M	8.03M	8.07M	8.14M	8M	7.82M	7.98M	16.55M
Basic Shares Outstanding	5.12M	5.39M	7.6M	6.44M	6.58M	6.73M	6.73M	6.73M	7.23M	14.85M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

SMLR Balance Sheet

Semler Scientific, Inc. (SMLR) balance sheet — assets, liabilities & shareholders' equity

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Total Current Assets	1.59M	2.88M	6.24M	11.44M	26.6M	45.54M	48.91M	65.94M	22.69M	53.51M
Cash & Short-Term Investments	622K	1.46M	3.28M	7.74M	22.08M	37.32M	43.09M	57.2M	14.92M	10.18M
Cash Only	622K	1.46M	3.28M	7.74M	22.08M	37.32M	23.01M	57.2M	8.82M	10.18M
Short-Term Investments	0	0	0	0	0	0	20.07M	0	6.1M	0
Accounts Receivable	877K	1.31M	2.8M	3.49M	2.81M	3.62M	3.88M	6.13M	4.38M	38.49M
Days Sales Outstanding	43.06	38.55	47.57	38.83	26.55	24.91	25.01	32.79	28.39	120.58
Inventory	-877K	-1.31M	-2.8M	0	340K	550K	469K	445K	358K	485K
Days Inventory Outstanding	-	-	-	-	36.98	32.79	40.26	23.26	27.46	47.34
Other Current Assets	0	0	0	0	0	0	0	2.17M	3.03M	4.09M
Total Non-Current Assets	1.48M	1.35M	1.48M	6.84M	8.04M	5.14M	13.79M	12.12M	217.14M	543.17M
Property, Plant & Equipment	1.47M	1.34M	1.47M	2.33M	2.2M	2.04M	3.15M	3M	1.91M	1.66M
Fixed Asset Turnover	5.07x	9.29x	14.66x	14.08x	17.53x	26.03x	18.02x	22.69x	29.47x	20.27x
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	214.63M	539.84M
Long-Term Investments	0	0	0	0	3.05M	821K	5.5M	5.88M	512K	2.05M
Other Non-Current Assets	15K	15K	15K	15K	418K	332K	2.84M	270K	85K	4.26M
Total Assets	3.07M▲ 0%	4.24M▲ 38.0%	7.72M▲ 82.1%	18.29M▲ 136.9%	34.64M▲ 89.4%	50.67M▲ 46.3%	62.69M▲ 23.7%	78.06M▲ 24.5%	239.83M▲ 207.2%	596.68M▲ 0%
Asset Turnover	2.42x	2.94x	2.78x	1.79x	1.11x	1.05x	0.90x	0.87x	0.23x	0.09x
Asset Growth %	-0.23%	37.96%	82.14%	136.91%	89.42%	46.29%	23.72%	24.52%	207.22%	1520.72%
Total Current Liabilities	3.23M	5.14M	3.51M	5.21M	4.51M	4.88M	6.86M	6.2M	6.31M	27.22M
Accounts Payable	450K	488K	280K	338K	677K	443K	835K	402K	140K	200K
Days Payables Outstanding	87.69	69.77	37.81	33.7	73.63	26.41	71.68	21.01	10.74	29.03
Short-Term Debt	81K	1.25M	0	0	0	0	0	0	0	20M
Deferred Revenue (Current)	513K	531K	435K	955K	963K	921K	1.16M	1.12M	774K	2.53M
Other Current Liabilities	704K	591K	355K	1.04M	1.6M	523K	2.5M	2.09M	3.9M	3.68M
Current Ratio	0.49x	0.56x	1.78x	2.20x	5.89x	9.33x	7.13x	10.64x	3.59x	3.59x
Quick Ratio	0.76x	0.82x	2.57x	2.20x	5.82x	9.22x	7.06x	10.56x	3.54x	3.54x
Cash Conversion Cycle	-	-	-	-	-10.1	31.29	-6.41	35.04	45.11	138.89
Total Non-Current Liabilities	2.76M	1.68M	11K	7K	332K	245K	160K	70K	2.77M	109.71M
Long-Term Debt	2.53M	1.67M	0	0	0	0	0	0	0	96.42M
Capital Lease Obligations	0	0	0	0	0	245K	160K	70K	0	0
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	2.77M	22.22M
Other Non-Current Liabilities	230K	13K	11K	7K	332K	0	0	0	0	0
Total Liabilities	5.99M	6.82M	3.52M	5.21M	4.85M	5.13M	7.02M	6.27M	9.08M	136.93M
Total Debt	2.61M	2.92M	0	0	0	325K	245K	160K	70K	116.42M
Net Debt	1.99M	1.47M	-3.28M	-7.74M	-22.08M	-37M	-22.77M	-57.04M	-8.75M	106.24M
Debt / Equity	-	-	-	-	-	0.01x	0.00x	0.00x	0.00x	0.00x
Debt / EBITDA	-	-	-	-	-	0.02x	0.01x	0.01x	0.00x	-3.37x
Net Debt / EBITDA	-	-	-0.56x	-0.68x	-1.34x	-1.84x	-1.28x	-2.50x	-0.41x	-0.41x
Interest Coverage	-5.52x	-1.84x	17.93x	-	-	-	-	-	-	-12.85x
Total Equity	-2.92M▲ 0%	-2.58M▲ 11.5%	4.2M▲ 262.4%	13.07M▲ 211.6%	29.79M▲ 127.9%	45.55M▲ 52.9%	55.68M▲ 22.2%	71.8M▲ 29.0%	230.75M▲ 221.4%	459.75M▲ 0%
Equity Growth %	-172.29%	11.51%	262.45%	211.56%	127.9%	52.88%	22.24%	28.95%	221.4%	1156.62%
Book Value per Share	-0.57	-0.48	0.55	1.63	3.69	5.60	6.96	9.18	28.92	27.79
Total Shareholders' Equity	-2.92M	-2.58M	4.2M	13.07M	29.79M	45.55M	55.68M	71.8M	230.75M	459.75M
Common Stock	5K	6K	6K	7K	7K	7K	7K	7K	9K	15K
Retained Earnings	-24.92M	-26.43M	-21.42M	-6.33M	7.67M	24.89M	39.22M	59.8M	100.7M	119.83M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-656K	-829K	-234K	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

SMLR Cash Flow Statement

Semler Scientific, Inc. (SMLR) cash flow — operating, investing & free cash flow history

Line item	Dec'16	Dec'17	Dec'18	Dec'19	Dec'20	Dec'21	Dec'22	Dec'23	Dec'24	TTM
Cash from Operations	-1.8M	621K	4.7M	12.73M	15.11M	16.06M	17.46M	17.82M	24.41M	24.41M
Operating CF Margin %	-24.27%	4.99%	21.86%	38.84%	39.15%	30.28%	30.81%	26.14%	43.36%	-
Operating CF Growth %	56.37%	134.42%	656.36%	170.98%	18.75%	6.23%	8.76%	2.04%	36.98%	-139.43%
Net Income	-2.55M	-1.51M	5.01M	15.08M	14.01M	17.22M	14.32M	20.58M	40.9M	48.34M
Depreciation & Amortization	452K	559K	503K	632K	576K	628K	589K	599K	579K	416K
Stock-Based Compensation	300K	343K	601K	0	253K	749K	741K	0	862K	3.74M
Deferred Taxes	331K	718K	246K	-4.5M	2.14M	408K	-351K	-664K	5.73M	16.61M
Other Non-Cash Items	185K	330K	253K	619K	-128K	1.63M	489K	1.04M	-24.85M	-97.97M
Working Capital Changes	-518K	181K	-1.92M	894K	-1.73M	-4.58M	1.67M	-3.74M	1.19M	1.95M
Change in Receivables	293K	-479K	-1.5M	-734K	623K	-874K	-367K	-2.51M	1.84M	4.29M
Change in Inventory	17K	606K	-113K	0	-303K	-1.41M	81K	24K	88K	-104K
Change in Payables	-389K	38K	-208K	58K	339K	-234K	392K	-433K	-262K	-345K
Cash from Investing	-814K	-968K	-843K	-1.7M	-1.01M	-825K	-26.84M	18.4M	-189.98M	-405.76M
Capital Expenditures	-814K	-971K	-844K	-1.7M	-758K	-825K	-2.16M	-828K	-51K	-49.18M
CapEx % of Revenue	10.95%	7.8%	3.93%	5.18%	1.96%	1.56%	3.81%	1.21%	0.09%	-
Acquisitions	0	3K	1K	0	0	0	0	0	0	0
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-591K	3K	1K	0	-248K	0	0	-1M	-189.43M	-355.43M
Cash from Financing	2.83M	1.18M	-2.03M	-6.57M	230K	13K	-4.94M	-1.9M	117.19M	436.28M
Debt Issued (Net)	2.83M	-32K	-2.9M	0	0	0	0	0	0	120M
Equity Issued (Net)	0	475K	0	-1000K	0	0	-1000K	-1000K	1000K	2M
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	0	0	0	-6.63M	0	0	-4.99M	-1.95M	0	-7.74M
Other Financing	0	739K	870K	0	230K	13K	54K	0	-2.41M	-7.39M
Net Change in Cash	217K▲ 0%	835K▲ 284.8%	1.83M▲ 118.8%	4.46M▲ 144.0%	14.34M▲ 221.7%	15.24M▲ 6.3%	-14.31M▼ 193.9%	34.32M▲ 339.8%	-48.38M▼ 241.0%	3.61M▲ 0%
Free Cash Flow	-2.62M▲ 0%	-350K▲ 86.6%	3.85M▲ 1200.9%	11.03M▲ 186.3%	14.36M▲ 30.2%	15.23M▲ 6.1%	15.3M▲ 0.5%	16.99M▲ 11.0%	-165.34M▼ 1073.1%	-388.75M▲ 0%
FCF Margin %	-35.22%	-2.81%	17.93%	33.66%	37.19%	28.72%	27%	24.92%	-293.71%	-1051.92%
FCF Growth %	50.03%	86.63%	1200.86%	186.27%	30.15%	6.09%	0.47%	11.04%	-1073.05%	-672.66%
FCF per Share	-0.51	-0.06	0.51	1.37	1.78	1.87	1.91	2.17	-20.72	-20.72
FCF Conversion (FCF/Net Income)	0.71x	-0.41x	0.94x	0.84x	1.08x	0.93x	1.22x	0.87x	0.60x	-8.04x
Interest Paid	0	0	575K	0	0	0	0	0	0	0
Taxes Paid	0	0	18K	0	285K	2.65M	2.4M	0	2.26M	0

SMLR Key Ratios

Semler Scientific, Inc. (SMLR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric	2016	2017	2018	2019	2020	2021	2022	2023	2024	TTM
Return on Equity (ROE)	-	-	621.7%	174.69%	65.35%	45.72%	28.3%	32.29%	27.04%	10.51%
Return on Invested Capital (ROIC)	-	-	439.31%	257.24%	183.52%	179.35%	62.25%	70.04%	13.26%	13.26%
Gross Margin	74.8%	79.5%	87.42%	88.83%	91.31%	88.45%	92.5%	89.76%	91.55%	90.76%
Net Margin	-34.36%	-12.13%	23.33%	46.03%	36.28%	32.48%	25.27%	30.19%	72.65%	130.8%
Debt / Equity	-	-	-	-	-	0.01x	0.00x	0.00x	0.00x	0.00x
Interest Coverage	-5.52x	-1.84x	17.93x	-	-	-	-	-	-	-12.85x
FCF Conversion	0.71x	-0.41x	0.94x	0.84x	1.08x	0.93x	1.22x	0.87x	0.60x	-8.04x
Revenue Growth	6.18%	67.5%	72.59%	52.47%	17.81%	37.36%	6.9%	20.28%	-17.44%	-37.29%

SMLR SEC Filings & Documents

Semler Scientific, Inc. (SMLR) SEC filings — annual & quarterly reports (10-K, 10-Q)

8-K Announcements

Material company update

Jan 16, 2026·SEC

Material company update

Jan 13, 2026·SEC

Material company update

Dec 12, 2025·SEC

10-Q Quarterly Reports

FY 2025

Nov 12, 2025·SEC

SMLR Frequently Asked Questions

Semler Scientific, Inc. (SMLR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Semler Scientific, Inc. (SMLR) reported $37.0M in revenue for fiscal year 2024. This represents a 11595% increase from $0.3M in 2011.

Semler Scientific, Inc. (SMLR) saw revenue decline by 17.4% over the past year.

Yes, Semler Scientific, Inc. (SMLR) is profitable, generating $48.3M in net income for fiscal year 2024 (72.7% net margin).

Dividend & Returns

Semler Scientific, Inc. (SMLR) has a return on equity (ROE) of 27.0%. This is excellent, indicating efficient use of shareholder capital.

Semler Scientific, Inc. (SMLR) had negative free cash flow of $388.7M in fiscal year 2024, likely due to heavy capital investments.

Explore More SMLR

Semler Scientific, Inc. (SMLR) financial analysis — history, returns, DCA and operating performance tools

Total Return Calculator

Historical returns with dividends reinvested

→

DCA Calculator

Dollar cost averaging vs lump sum

→

Dividend History

Yield, growth, payout safety & DRIP

→

Earnings History

EPS trends, net income & profitability

→

Price History

Long-term charts & historical price data

→

Revenue History

Sales growth patterns & revenue breakdown

→

Financial Ratios

30 years of market, efficiency and balance-sheet ratios

→

Valuation

DCF intrinsic value, peer multiples & estimates

→

Semler Scientific, Inc.(SMLR)Earnings, Financials & Key Ratios

SMLR Key Insights

✓Strengths

✗Weaknesses

SMLR Price & Volume

SMLR Growth Metrics

Revenue CAGR

Profit CAGR

EPS CAGR

Return on Capital

SMLR Recent Earnings

SMLR Peer Comparison

Compare SMLR vs Peers

vs BEAT

vs UNH

Compare Top 5

SMLR Income Statement

SMLR Balance Sheet

SMLR Cash Flow Statement

SMLR Key Ratios

SMLR SEC Filings & Documents

8-K Announcements

10-Q Quarterly Reports

SMLR Frequently Asked Questions

Explore More SMLR

Total Return Calculator

DCA Calculator

Dividend History

Earnings History

Price History

Revenue History

Financial Ratios

Valuation